Alzamend Neuro, Inc. (NASDAQ:ALZN)
| Market Cap | $3.74M-62.7% |
| Revenue (ttm) | $0 |
| Net Income | -$9.10M-45.7% |
| EPS | -$2.30+74.5% |
| Shares Out | 4.83M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 93,127 |
| Open | $0.89 |
| Previous Close | $1.02 |
| Day's Range | $0.76 - $0.89 |
| 52-Week Range | $0.75 - $2.54 |
| Beta | 0.19 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Dec 8, 2026 |
About ALZN
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Dec 8, 2026Earnings report
$ALZN stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ALZN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ALZN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ALZN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ALZN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ALZN from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ALZN
| VXFVanguard Extended Market ETF | $43.81K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from ALZN’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
-55.0 since Aug 31Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
